The Laboratory tubes

Product

2022 China New Design L-Carnosine - Tacrolimus monohydrate 109581-93-3 Antibiotic – Neore

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

To meet the customers' over-expected satisfaction , we have our strong team to provide our best overall service which includes marketing, sales, designing, production, quality controlling, packing, warehousing and logistics for AHK-Cu 49557-75-7, 217500-96-4, 1077-28-7, Our goal is "blazing new ground, Passing Value", in the potential, we sincerely invite you to mature up with us and create a vivid foreseeable future jointly!
2022 China New Design L-Carnosine - Tacrolimus monohydrate 109581-93-3 Antibiotic – Neore Detail:

Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 1kg/month
Order(MOQ): 1g
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: vial, bottle
Package size: 1g/vial, 5/vial, 10g/vial, 50g/bottle, 500g/bottle
Safety information:  UN 2811 6.1/PG 3

Tacrolimus monohydrate

Introduction

Tacrolimus, is an immunosuppressive drug. After allogeneic organ transplant, the risk of organ rejection is moderate. To lower the risk of organ rejection, tacrolimus is given. The drug can also be sold as a topical medication in the treatment of T-cell-mediated diseases such as eczema and psoriasis. It can be used to treat dry eye syndrome in cats and dogs.

Tacrolimus inhibits calcineurin, which is involved in the production of interleukin-2, a molecule that promotes the development and proliferation of T cells, as part of the body’s learned (or adaptive) immune response.

Specification (USP43)

Item

Specification

Appearance

White or almost white crystalline powder

Identification

IR, HPLC

Solubility

Very soluble in methanol, freely soluble in N,N dimethylformamide and in alcohol, practically in soluble in water.

Residue on ignition

≤0.10 %

Organic impurities

 (procedure-2)

Ascomycin 19-epimer ≤0.10 %

Ascomycin ≤0.50 %

Desmethyl tacrolimus ≤0.10 %

Tacrolimus 8-epimer ≤0.15 %

Tacrolimus 8-propyl analog ≤0.15 %

Unknown impurity -I ≤0.10 %

Unknown impurity -II ≤0.10 %

Unknown impurity -III ≤0.10 %

Total impurities ≤1.00 %

Optical rotation (on as is basis)

 (10mg/ml in N,Ndimethylformamide)

-110.0° ~ -115.0°

Water content (by KF)

≤4.0%

Residual solvents (by GC)

Acetone ≤1000ppm (In-house)

Di-isopropyl ether ≤100ppm (In-house)

Ethyl ether ≤5000ppm

Acetonitrile ≤410ppm

Toluene ≤890ppm

Hexane ≤290ppm

Microbial test (in house)

Total aerobic microbial count ≤100cfu/gm

Total yeast and mould count ≤10cfu/gm

Specified organisms (Pathogens) (E.coil, salmonella sps., S.aureus. Pseudomonas aeruginosa) should absent

Assay (by HPLC) (on anhydrous and solvent free basis)

98%~102%


Product detail pictures:

2022 China New Design L-Carnosine  - Tacrolimus monohydrate 109581-93-3 Antibiotic – Neore detail pictures


Related Product Guide:

Fast and very good quotations, informed advisers to help you choose the correct merchandise that suits all your preferences, a short creation time, responsible excellent command and different companies for paying and shipping affairs for 2022 China New Design L-Carnosine - Tacrolimus monohydrate 109581-93-3 Antibiotic – Neore , The product will supply to all over the world, such as: Hamburg, Qatar, Swiss, Our company warmly invites domestic and overseas customers to come and negotiate business with us. Allow us to join hands to create a brilliant tomorrow! We've been looking forward to cooperating with you sincerely to achieve a win-win situation. We promise to try our best to deliver you with high quality and efficient services.
  • The company has a good reputation in this industry, and finally it tured out that choose them is a good choice.
    5 Stars By John biddlestone from Netherlands - 2017.03.28 16:34
    After the signing of the contract, we received satisfactory goods in a short term, this is a commendable manufacturer.
    5 Stars By Riva from Marseille - 2017.08.28 16:02